Establishment and Phenotypic Characterization of Human U937 Cells With Inducible P210 BCR/ABL Expression Reveals Upregulation of CEACAM1 (CD66a)

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genomic Mechanisms of P210 BCR-ABL Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Arginine Butyrate Downregulates P210 BCR-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

IPO-trimethylation of Histone H3-Lysine9associated With P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia

British Journal of Haematology
Hematology
2008English

All Common P210 and P190 BCR-Abl Variants Can Be Targeted by RNA Interference

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Expression of BCR-Abl Abrogates Factor-Dependent Growth of Human Hematopoietic M07E Cells by an Autocrine Mechanism

Blood
BiochemistryImmunologyCell BiologyHematology
1994English

Induction of BCR-ABL-specific Immunity Following Vaccination With Chaperone-Rich Cell Lysates Derived From BCR-ABL+ Tumor Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

P210 and P190 BCR-ABL Fusion Transcripts Variants Frequencies Among Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Sudan

International Journal of Biomedical Research
2018English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy